Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Fasting may reduce chemotherapy side effects.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Clofazimine effectively treated ashy dermatosis in a patient.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Skin and nail changes are common in patients with blood cancers undergoing chemotherapy, affecting their quality of life.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

Epidermal growth factor helps hair regrow after chemotherapy.

Chemotherapy toxicity might be reduced by using DNA neutralizing agents.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

2% Minoxidil does not prevent hair loss during chemotherapy.